Results 191 to 200 of about 2,005,946 (309)
Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy. [PDF]
An R, Shao Y, Gu W.
europepmc +1 more source
ABSTRACT Objectives WHO grade 4 astrocytomas are associated with poor prognosis, and their prognostic factors remain controversial. This study aimed to identify the prognostic factors and develop a management algorithm for these patients. Methods This study retrospectively included 151 CNS5 adult grade 4 astrocytomas from two medical centers.
Jiawei Cai +13 more
wiley +1 more source
The role and clinical value of natriuretic peptide receptor family in malignant tumor. [PDF]
Quan C +5 more
europepmc +1 more source
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye +11 more
wiley +1 more source
A endometrial malignant tumor with yolk sac tumor component: a case report and literature review. [PDF]
Cui Z, Shan Y, Chu H, Chen A.
europepmc +1 more source
Pelvic Malignant Tumor with Liver Metastasis is Actually Conventional Leiomyoma with Abdominal Metastasis. [PDF]
Yang J, Lu J.
europepmc +1 more source
Clinical features and risk factors for poor prognosis in malignant tumor patients with pulmonary embolism: a case control study. [PDF]
Dong K +9 more
europepmc +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Obese patients with malignant tumor: a case series and literature review. [PDF]
Liang P +8 more
europepmc +1 more source
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi +5 more
wiley +1 more source

